← Back to the Areas of Interest
Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC
View the full invitation
AstraZeneca – Navigating the complexity in NSCLC: Optimising the patient journey
MSD – Shifting paradigms for early-stage NSCLC: Asian oncologists’ perspectives
Roche – The emerging treatment landscape of targeted therapy and personalized healthcare in lung cancer